Abstract:Mutation in oncogene KRas plays a crucial role in the occurrence and progression of numerous malignant tumors. Malignancy involves changes in cell mechanics for extensive cellular deformation during metastatic dissemination. We hypothesize that oncogene KRas mutations are intrinsic to alterations in cellular mechanics that promote malignant tumor generation and progression. Here, we demonstrate the use of optical tweezers coupled with a confocal fluorescence imaging system and gene interference technique to reveal that the mutant KRas protein can be transported between homogeneous and heterogeneous tumor cells by tunneling nanotubes (TNTs), resulting in a significant reduction of membrane tension and acceleration of membrane phospholipid flow in the recipient cells. Simultaneously, the changes in membrane mechanical properties of the tumor cells also enhance the metastatic and invasive ability of the tumors, which further contribute to the deterioration of the tumors. This finding helps to clarify the association between oncogene mutations and changes in the mechanical properties of tumor cells, which provides a theoretical basis for the development of cancer treatment strategies. Statement of significance Here, we present a laser confocal fluorescence system integrated with optical tweezers to observe the transfer of mutant KRas G12D protein from mutant cells to wild-type cells through TNTs. Malignancy involves changes in cell mechanics for extensive cellular deformation during metastatic dissemination. Our results demonstrate a significant decrease in membrane tension and an increase in membrane phospholipid flow in recipient cells. These alterations in mechanical properties augment the migration and invasive capabilities of tumor cells, contributing to tumor malignancy. Our findings propose that cellular mechanical properties could serve as new markers for tumor development, and targeting membrane tension may hold potential as a therapeutic strategy.

[Nucleus Translocation of Membrane/cytoplasm Proteins in Tumor Cells].

Enhanced Nuclear Translation is Associated with Proliferation and Progression Across Multiple Cancers

Bifunctional Small Molecules That Induce Nuclear Localization and Targeted Transcriptional Regulation

Quantitation and localization of protein molecules in living cells

Protein Localization of a Tumor Metastasis Associated Gene TMSG-1

Protein Profiling: a Possible Molecular Mechanism to Mislocalization and Down-Expression of P27(kip1) in Tumor Cells.

Inner nuclear membrane protein TMEM201 promotes breast cancer metastasis by positive regulating TGFβ signaling

Advances in the role of membrane-bound transcription factors in carcinogenesis and therapy

Analysis of somatic mutations in membrane proteins of tumor cells

Localized Proteasomal Degradation: From the Nucleus to Cell Periphery

Advances on the Relationship Between Plasma Membrane Protein and Tumor

Tunneling nanotubes mediate KRas transport: Inducing tumor heterogeneity and altering cellular membrane mechanical properties

Nuclear Receptor-Induced Chromosomal Proximity and DNA Breaks Underlie Specific Translocations in Cancer

Targeted protein relocalization via protein transport coupling

Promising therapeutic targets for tumor treatment: Cleaved activation of receptors in the nucleus

Bioinformatics Research in Subcellular Localization of Protein

TC2N: A Novel Vital Oncogene or Tumor Suppressor Gene In Cancers

Chromosome compartmentalization alterations in prostate cancer cell lines model disease progression

Cell cycle and tumor translational medicine

Cytoplasmic expression of UTP23 promotes colorectal cancer progression

SNARE proteins: Core engines of membrane fusion in cancer